London
· Delayed Price · Currency is GBP · Price in GBXPureTech Health Statistics
Total Valuation
PureTech Health has a market cap or net worth of GBP 370.15 million. The enterprise value is 81.06 million.
| Market Cap | 370.15M |
| Enterprise Value | 81.06M |
Important Dates
The last earnings date was Thursday, November 28, 2024.
| Earnings Date | Nov 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PureTech Health has 239.42 million shares outstanding. The number of shares has decreased by -2.86% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 239.42M |
| Shares Change (YoY) | -2.86% |
| Shares Change (QoQ) | -1.71% |
| Owned by Insiders (%) | 6.64% |
| Owned by Institutions (%) | 73.23% |
| Float | 158.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.48 |
| P/TBV Ratio | 1.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.24 |
| EV / Sales | 218.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.47.
| Current Ratio | 3.68 |
| Quick Ratio | 3.63 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.80 |
Financial Efficiency
Return on equity (ROE) is -22.07% and return on invested capital (ROIC) is -15.66%.
| Return on Equity (ROE) | -22.07% |
| Return on Assets (ROA) | -13.39% |
| Return on Capital (ROIC) | -15.66% |
| Revenue Per Employee | 4,115 |
| Profits Per Employee | -725,032 |
| Employee Count | 90 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.25% in the last 52 weeks. The beta is 1.02, so PureTech Health's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -14.25% |
| 50-Day Moving Average | 162.02 |
| 200-Day Moving Average | 182.74 |
| Relative Strength Index (RSI) | 41.93 |
| Average Volume (20 Days) | 1,051,513 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PureTech Health had revenue of GBP 370,314 and -65.25 million in losses. Loss per share was -0.24.
| Revenue | 370,314 |
| Gross Profit | -64.53M |
| Operating Income | -107.96M |
| Pretax Income | -61.24M |
| Net Income | -65.25M |
| EBITDA | -106.61M |
| EBIT | -107.96M |
| Loss Per Share | -0.24 |
Balance Sheet
The company has 395.96 million in cash and 114.52 million in debt, giving a net cash position of 281.44 million or 1.18 per share.
| Cash & Cash Equivalents | 395.96M |
| Total Debt | 114.52M |
| Net Cash | 281.44M |
| Net Cash Per Share | 1.18 |
| Equity (Book Value) | 242.29M |
| Book Value Per Share | 1.04 |
| Working Capital | 293.16M |
Cash Flow
| Operating Cash Flow | -95.58M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -29,153.02% |
| Pretax Margin | -16,536.55% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PureTech Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.86% |
| Shareholder Yield | 2.86% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PureTech Health has an Altman Z-Score of 1.32. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.32 |
| Piotroski F-Score | n/a |